Skip to main content
logo
Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.190
-0.005 (-0.42%)
At close: Jul 29, 2026, 4:00 PM EDT
1.160
-0.030 (-2.52%)
After-hours: Jul 29, 2026, 6:48 PM EDT

Spero Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
61.1966.847.98103.7853.5118.26
Revenue Growth
37.24%39.24%-53.77%93.95%193.10%95.67%
Gross Profit
61.1966.847.98103.7853.5118.26
Operating Income
13.516.31-73.3621.48-42.2-87.97
Net Income
-7.29.09-68.5728-46.42-89.76
Earnings Per Share
0.240.15-1.270.43-1.23-2.91
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
56.1340.2752.8976.33109.11146.4
Total Debt
2.472.94.35.546.6555.75
Net Cash (Debt)
53.6637.3748.5970.79102.4690.65
Net Cash Growth
19.43%-23.09%-31.36%-30.91%13.02%-23.86%
Net Cash Per Share
0.940.630.901.342.732.93

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
7.24-12.62-23.44-33-7.73-64.35
Free Cash Flow
7.24-12.62-23.44-33-7.73-64.35
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
22.08%9.45%-152.91%20.70%-78.86%-481.87%
Pretax Margin
25.33%13.22%-142.91%24.48%-86.74%-491.65%
Profit Margin
-11.77%13.61%-142.91%26.98%-86.74%-491.65%
FCF Margin
11.84%-18.90%-48.87%-31.79%-14.45%-352.47%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
4.5615.53-3.42--
Forward PE
-4.88----
PS Ratio
1.131.971.170.751.7033.99